Business
Currency:USD
2024/Q3
Stock NameRevenueRatio
Nucleic acid production49.95M76.61%
Biologics safety testing15.25M23.39%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
North America141.06M48.82%
Asia Pacific97.44M33.72%
Europe, the Middle East and Africa49.92M17.28%
Latin and Central America527K0.18%
